期刊文献+

头颈部鳞状细胞癌术后放疗控制颈部淋巴结转移的临床病理学影响因素分析 被引量:11

Analyses of clinicopathologic factors affecting neck control after postoperative radiation as adjuvant treatment for lymph node metastasis in head and neck squamous cell carcinoma
原文传递
导出
摘要 目的 探讨术后辅助放疗控制头颈部鳞状细胞癌(简称头颈鳞癌)颈淋巴结转移的效果和影响颈部复发及远处转移的临床病理学因素.方法 回顾性分析208例接受术后颈部辅助放疗的病理性颈淋巴结转移(pN+)的头颈鳞癌患者的临床病理学资料及随访结果.纳入研究的肿瘤原发灶相关临床病理学因素包括:性别、年龄、病理T分期,以及肿瘤部位、大小、病理分级、生长方式及手术切缘情况;纳入研究的颈淋巴结病理学因素包括:病理N分期、阳性淋巴结大小、数目、受侵分区数及包膜外侵犯(extracapsular spread,ECS)情况.应用x2检验及Logistic回归进行数据资料统计分析.结果 术后辅助放疗5年的治疗侧颈部控制率为72.6% (151/208),其中颈择区清扫术后颈部控制率为84.0%(63/75),颈改良清扫术后为72.9%(78/107),颈全清扫术后为38.5% (10/26).单因素分析显示,原发灶部位、pN分期、阳性淋巴结大小、阳性淋巴结受侵分区数、阳性淋巴结数目以及阳性淋巴结ECS与治疗侧颈部控制率明显相关;pN分期、阳性淋巴结受侵分区数与患者出现远处转移有关.多因素回归分析显示,阳性淋巴结ECS是影响pN+头颈鳞癌患者治疗侧颈部控制率最重要因素;阳性淋巴结受侵分区数是影响远处转移最重要的淋巴结病理学因素.结论 淋巴结ECS是术后制定辅助治疗方案最重要的肿瘤病理学指标,应常规术后病理评价;对于颈转移伴有ECS的患者,术后辅助放疗在控制颈部复发中的作用有限,而阳性淋巴结受侵分区数(>1)是影响远处转移最重要的淋巴结病理学因素;对这些病理因素应实施包括同步放化疗、靶向治疗在内的更加积极的治疗方案,以减少和控制颈部复发和远处转移. Objective To investigate the clinicopathologic factors associated with neck control and distant metastasis in patients with neck metastases in head and neck squamous cell carcinoma (HNSCC)after postoperative radiation as adjuvant treatment.Methods Clinicopathologic data of 208 pathologic N + (pN +) patients with HNSCC initially treated with neck dissection and postoperative radiation in Bethune International Peace Hospital of China from January 2004 to December 2009 were reviewed.The clinicopathologic factors,includeding age,sex,primary tumor site,pathologic T and N stage,tumor growth pattern,histological grade,tumor resection margin,size and number of positive lymph node,number of levels with positive lymph node,and extracapsular nodal spread (ECS),were evaluated for their association with neck control and distant metastasis in patients with HNSCC after postoperative radiation.Univariate x2 test and multiple stepwise logistic regression model were used for the analysis.Results Overall 5-year neck control rate after postoperative radiotherapy was 72.6% (151/208),with 84.0% (63/75) for SND,72.9% (78/107) for MRND,and 38.5% (10/26) for RND,respectively.Univariate analysis showed that neck control after postoperative radiation was related with following factors:primary tumor site,pathologic N stage,size of positive node,number of levels with positive node,number of positive node,and ECS.Pathologic N stage and number of levels with positive lymph node were associated with distant metastasis.Multivariate analysis indicated that ECS was the most significant risk factor for neck metastasis after surgery and postoperative radiotherapy and the number of levels with positive node was the most significant risk factor for distant metastasis.Conclusions ECS is the most important pathologic factor in planning postoperative adjuvant treatment for pN + patients with HNSCC,therefore ECS should be evaluated routinely after neck dissection.The value of postoperative radiotherapy in controlling th
出处 《中华耳鼻咽喉头颈外科杂志》 CAS CSCD 北大核心 2016年第7期485-490,共6页 Chinese Journal of Otorhinolaryngology Head and Neck Surgery
关键词 头颈部肿瘤 鳞状细胞 淋巴转移 放射疗法 复发 病理学 临床 Head and neck neoplasms Carcinoma,squamous cell Lymphatic metastasis Radiotherapy Recurrence Pathology,clinical
  • 相关文献

参考文献17

  • 1Li X, Di B, Shang Y, et al. Clinicopathologic risk factors fordistant metastases from head and neck squamous cell carcinomas[J]. Eur J Surg Oncol, 2009, 35 ( 12) : 1348-1353. 被引量:1
  • 2钱薇,朱国培,嵇庆海,郭晔,王宇,王玉龙.125例局部晚期头颈部鳞癌患者综合治疗的疗效和预后分析[J].中华肿瘤杂志,2014,36(3):217-222. 被引量:4
  • 3李晓明.头颈部鳞状细胞癌颈淋巴结转移处理的专家共识[J].中华耳鼻咽喉头颈外科杂志,2016,51(1):25-33. 被引量:25
  • 4Fletcher GH,Evers WT. Radiotherapeutic management of surgicalrecurrences and postoperative residuals in tumors of the head andneck[J]. Radiology, 1970, 95; 185-188. 被引量:1
  • 5Gavilan J, Prim MP, De Diego JI, et al. Postoperativeradiotherapy in patients with positive nodes after functional neckdissection[ J]. Ann Otol Rhinol Laryngol, 2000,109 : 844-848.DOI: http://dx. doi. org/10. 1177/000348940010900911. 被引量:1
  • 6Hinerman RW, Morris CG, Amdur RJ, et al. Surgery andpostoperative radiotherapy for squamous cell carcinoma of thelarynx and pharynx[ J]. Am J Clin Oncol, 2006, 29: 613-621.DOI: http://dx. doi. org/10. 1097/01. coc. 0000242319. 09994.78. 被引量:1
  • 7Buck G,Huguenin P,Stoeckli SJ. Efficacy of neck treatment inpatients with head and neck squamous cell carcinoma [ J ]. HeadNeck, 2008,30: 50-57. 被引量:1
  • 8Mendenhall WM, Amdur RJ, Hinerman RW, et al. Postoperativeradiation therapy for squamous cell carcinoma of the head and neck[J]. Am J Otolaryngol, 2003, 24: 41-50. 被引量:1
  • 9Johnson JT,Barnes EL, Myers EN,et al. The extracapsularspread of tumors in cervical node metastasis [ J ]. ArchOtolaryngol, 1981,107: 725-729. 被引量:1
  • 10Coatesworth AP, MacLennan K. Squamous cell carcinoma of theupper aerodigestive tract : the prevalence of microscopicextracapsular spread and soft tissue deposits in the clinically NOneck[ J ]. Head Neck, 2002, 24: 258-261. 被引量:1

二级参考文献43

共引文献27

同被引文献105

  • 1中国甲状腺疾病诊治指南——甲状腺功能亢进症[J].中华内科杂志,2007,46(10):876-882. 被引量:841
  • 2Lang J, Gao L, Guo Y, et al. Comprehensive treatment ofsquamous cell cancer of head and neck : Chinese expert consensus2013[ J]. Future Oncol, 2014, 10(9) : 1635-1648. 被引量:1
  • 3Friedland PL, Bozic B, Dewar J, et al. Impact ofmultidisciplinary team management in head and neck cancerpatients[J]. Br J Cancer,2011,104(8); 1246-1248. 被引量:1
  • 4Bradley PJ. Multidisciplinary clinical approach to the managementof head and neck cancer [ J ]. Eur Arch Otorhinolaryngol, 2012,269(12) ; 2451-2454. 被引量:1
  • 5Prades J, Remue E, van Hoof E, et al. Is it worth reorganisingcancer services on the basis of multidisciplinary teams (MDTs) ? Asystematic review of the objectives and organisation of MDTs andtheir impact on patient outcomes [ J ]. Health Policy, 2015,119(4). 464-474. 被引量:1
  • 6Perri F,Muto P, Aversa C, et al. Integrated therapeuticapproaches in head and neck cancer: the importance ofmultidisciplinary team management [ J ]. Anticancer Agents MedChem. 2013, 13(6) : 834-843. 被引量:1
  • 7Fujii M. Multidisciplinary approach for the treatment of head andneck cancer [ J ]. Int J Clin Oncol, 2014, 19 (2): 209-210. 被引量:1
  • 8Bernier J, Cooper JS, Pajak TF, et al. Defining risk levels inlocally advanced head and neck cancers : a comparative analysis ofconcurrent postoperative radiation plus chemotherapy trials of theEORTC (#22931) and RTOG (#9501) [J]. Head Neck, 2005,27(10) : 843-850. 被引量:1
  • 9Lefebvre JL,Chevalier D,Luboinski B,et al. Larynx preservationin pyriform sinus cancer: preliminary results of a EuropeanOrganization for Research and Treatment of Cancer phase III trial.EORTC Head and Neck Cancer Cooperative Group [ J ]. J NatlCancer Inst, 1996, 88(13) : 890-899. 被引量:1
  • 10Forastiere AA, Goepfert H, Maor M, et al. Concurrentchemotherapy and radiotherapy for organ preservation in advancedlaryngeal cancer [ J ]. N Engl J Med, 2003 , 349(22): 2091-2098. 被引量:1

引证文献11

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部